BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2009
View Archived Issues
MicroDose Therapeutx acquires investigational RSV therapeutics from ViroPharma
Read More
Antisoma presents update on its clinical development activities
Read More
CEM-101 active against drug-resistant S. pneumoniae isolates from 3 continents
Read More
Benefit of PRX-032 in benign prostatic hyperplasia lasts at least one year
Read More
Phase III H5N1 vaccine safe and strongly immunogenic
Read More
ErbB4 gene variation linked to paliperidone response in schizophrenia patients
Read More
TMC-435 retreatment successful in HCV patients
Read More
Vernalis provides update on its clinical development activities
Read More
European Commission grants orphan drug status to MolMed's NGR-hTNF in HCC
Read More
Genfit to utilize stem cell research and targeting of nuclear receptors
Read More
Novo Nordisk reports results from third quarter of 2009
Read More
INX-189 exhibits anti-HCV activity in vitro and extensive liver delivery in vivo
Read More
HIV infection therapeutic TBR-652 shows good PK and safety profile in healthy subjects
Read More
Mintek claims novel compounds as apoptosis inducers for cancer treatment
Read More
Orexin receptor antagonists reported by Roche for the treatment of sleep disorders
Read More
Novel GR agonists for the treatment of asthma discovered by AstraZeneca
Read More
Glenmark describes CB1 and CB2 receptor ligands for the treatment of obesity
Read More
Shire reports results from emotional lability analysis in pediatric ADHD patients on Vyvanse
Read More
Adolor initiates testing in opioid bowel dysfunction program
Read More
Optimer completes enrollment in second phase III fidaxomicin trial
Read More
Abbott acquires novel investigational antibody for chronic pain
Read More
LEO Pharma acquires Peplin
Read More
NicOx reports results from phase Ib study of cholesterol-lowering agent NCX-6560
Read More
Transgene initiates enrollment into phase I trial of TG-4023 for liver cancer
Read More
BioInvent and Daiichi Sankyo to collaborate in the discovery of therapeutic antibodies
Read More
Synergy to fund phase IIa clinical trial of SP-304 for treatment of chronic constipation
Read More